2014
DOI: 10.1371/journal.pone.0109409
|View full text |Cite
|
Sign up to set email alerts
|

Group VIB Calcium-Independent Phospholipase A2 (iPLA2γ) Regulates Platelet Activation, Hemostasis and Thrombosis in Mice

Abstract: In platelets, group IVA cytosolic phospholipase A2 (cPLA2α) has been implicated as a key regulator in the hydrolysis of platelet membrane phospholipids, leading to pro-thrombotic thromboxane A2 and anti-thrombotic 12-(S)-hydroxyeicosatetranoic acid production. However, studies using cPLA2α-deficient mice have indicated that other PLA2(s) may also be involved in the hydrolysis of platelet glycerophospholipids. In this study, we found that group VIB Ca2+-independent PLA2 (iPLA2γ)-deficient platelets showed decre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
13
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 32 publications
1
13
0
Order By: Relevance
“…Consistent with a protective role of iPLA 2 ␥ in this process, the survival rates were lowered and tissue parasitism amplifi ed in T. cruziinfected iPLA 2 ␥ -null mice, suggesting that iPLA 2 ␥ activity affords protection against acute state cardiomyopathy in Chagas' disease ( 83 ). In contrast, iPLA 2 ␥ -defi ciency has been shown to increase bleeding time and provide resistance to thromboembolism ( 84 ), raising the possibility of targeting iPLA 2 ␥ for antithrombotic drug development. To date, the only reported clinical manifestation relating to iPLA 2 ␥ is a report that its absence is associated with myocardial dysfunction, cognitive defects, and mitochondrial degeneration ( 85 ) in a case study that closely parallels the phenotype in iPLA 2 ␥ -null mice ( 73 ).…”
mentioning
confidence: 75%
“…Consistent with a protective role of iPLA 2 ␥ in this process, the survival rates were lowered and tissue parasitism amplifi ed in T. cruziinfected iPLA 2 ␥ -null mice, suggesting that iPLA 2 ␥ activity affords protection against acute state cardiomyopathy in Chagas' disease ( 83 ). In contrast, iPLA 2 ␥ -defi ciency has been shown to increase bleeding time and provide resistance to thromboembolism ( 84 ), raising the possibility of targeting iPLA 2 ␥ for antithrombotic drug development. To date, the only reported clinical manifestation relating to iPLA 2 ␥ is a report that its absence is associated with myocardial dysfunction, cognitive defects, and mitochondrial degeneration ( 85 ) in a case study that closely parallels the phenotype in iPLA 2 ␥ -null mice ( 73 ).…”
mentioning
confidence: 75%
“…iPLA 2 γ also participates in the generation of lipid mediators under certain conditions. Pnpla8 −/− mice display reduced ADP- or collagen-stimulated TXA 2 generation by platelets ex vivo and show prolonged bleeding time and reduced pulmonary thromboembolism in vivo [ 132 ]. Cardiomyocyte-specific deletion of iPLA 2 γ decreases infarct size upon ischemia/reperfusion, with reduction of oxygenated metabolites of ω3 and ω6 PUFAs including PGs, HETEs, and hydroxy-DHAs [ 133 ].…”
Section: The Ipla 2 /Pnpla Familymentioning
confidence: 99%
“…The unique properties of plasmalogens influence membrane structure and molecular dynamics, modulate the function of integral membrane proteins, and contribute to the phospholipase-mediated release of signaling fatty acids during cellular stimulation (5)(6)(7)(8)(9). Deficiencies in plasmalogen content have identified important roles for these specialized phospholipids in modulating signal transduction (10), cell proliferation (11), cholesterol trafficking (12), and sensitivity to oxidative stress (13,14). Moreover, human genetic mutations leading to deficiencies in plasmalogen biosynthesis (e.g.…”
mentioning
confidence: 99%